Patrick Yat

Company: IntelliPharmaCeutics Position: V.P. Chemistry and Analytical Services Industry: Pharmaceutical Country: Canada

Dr. Patrick N. Yat is currently V.P. Chemistry and Analytical Services at IntelliPharmaCeutics Corp.  He has been in the pharmaceutical or pharmaceutical related industry since 1992.  Dr. Yat’s Ph.D. research on Opioid analgesics was supported by the pharmaceutical industry.

As a Visiting Research Scientist under NSERC, Dr. Yat worked in the Pharmaceutical Division of Heath Canada, where he was involved in client methods validation under DIN submissions as well as in methods development and validation for inclusion in pharmacopoeia.   Dr. Yat’s one-year term at Health Canada was further extended to the maximum two years, which saw him carrying out synthesis of enalapril metabolites and developing HPLC chiral methods for that compound.

As the core scientist involved in the development of HPLC methods for nutriceuticals for the American Botanical Council, Dr. Yat, while at the University of Ottawa, was in charge of methods development and analysis for ginseng products sold in the North American market.   The ginseng methodology from this contribution is now part of the current U.S. Pharmacopoeia.  Dr. Yat held the title of Research Associate at the University of Ottawa, and stood in at times to offer specialized lectures on phytochemistry to graduate students.

Dr. Yat was also at Biovail Corporation in the mid 90’s, where he was involved in methods development and validation of the company’s pipeline products, as well as in heading the preformulation activity of the company. At Patheon Inc. in the late 90’s, he was instrumental in the successful take off of the Preformulation unit.

Dr. Yat joined the IntelliPharmaCeutics team in 2001. There, he continued to build the in-house analytical testing methods which are applied to all products developed at the Company. He has also overseen the general development of the Analytical department to its present status as a fully GMP compliant testing laboratory.

Dr. Yat currently sits as an expert committee member of the United States Pharmacopoeia on methods development, and is also on the advisory board of the Toronto Institute of Pharmaceutical Technology in its Quality Control program.

Latest Profiles

  • Richelieu Dennis

    Richelieu Dennis

    Born: Liberia; Position: Founder, CEO; Company: Sundial Brands; Industry: Personal Care; Country: United States

  • Steve Stoute

    Steve Stoute

    Born: June 26, 1970, Queens, New York City, New York; Position: Founder, CEO; Company: Translation LLC. ; Industry: Marketing and Advertising; Country: United States

  • William James Adams

    Born: March 15, 1975, Eastside, Los Angeles County, California, USA; Position: CEO & co-founder; Company: ; Industry: Information Technology and Services; Country: United States

Latest Articles

  • Kenneth I. Chenault to join General Catalyst

    Kenneth I. Chenault

    Ken Chenault to join General Catalyst as chairman and a managing director, making him one of the most powerful venture capitalists. Mr. Chenault spent the last 17 years as Chairman and CEO of American Express and was recently...

  • Kenneth I. Chenault to Join Airbnb's Board

    Kenneth I. Chenault

    Former American Express CEO, Kenneth I. Chenault will be joining the board of directors of Airbnb. The announcement comes one week after Facebook appointed Chenault to its board of directors. Mr. Chenault will be the first and...

  • Ken Chenault to Join Facebook Board of Directors

    Ken Chenault

    Ken Chenault, the outgoing CEO of American Express, is joining Facebook’s board of directors. The technology industry has come under fire in recent year because of their lack diversity. Mr. Chenault joining Facebook’s board is...

  • Richelieu Dennis' Sundial Brands to be Acquire by Unilever

    Richelieu Dennis' Sundial Brands is being acquired by Unilever, a British-Dutch transnational consumer goods company co-headquartered in Rotterdam, Netherlands and London, United Kingdom. Its products include Dove soap and Ben...

  • Richard Parsons, Former Time Warner CEO Launch New VC Firm

    Richard Parsons

    Richard D. Parsons, senior advisor to Providence Equity Partners, former chairman of Citigroup, and the former chairman and CEO of Time Warner and business partner Rachel Lam who founded the Time Warner Investments group...